| Abbreviation | Content |
| IMF | Intramuscular fat |
| ACADL | Long-chain acyl-CoA dehydrogenase |
| TNF | Tumor necrosis factor |
| PREF-1 | Preadipocyte Factor 1 |
| CEBPβ | CCAT enhancer binding protein |
| CEBPα | CCAT enhancer binding protein |
| PPARγ | Peroxisome proliferator activated receptor gamma |
| SREBP-1 | Sterol regulating element binding protein isoform 1 |
| AP2 | APETALA-2-Like transcription factor gene |
| LPL | Lipoprotein lipase |
| ACADCL | Very long chain acyl-CoA dehydrogenase |
| ACADM | Middle chain acyl-CoA dehydrogenase |
| ACADS | Short chain acyl-CoA dehydrogenases |
| OE ACADL | Over-expression ACADL vector |
| PCDNA3.1 | The control group of oe |
| SI ACADL | Interference of ACADL |
| NC | The negative control group of SI |
| GO | Gene Ontology |
| UXT | Ubiquitously expressed transcript |
| DEGs | Differentially expressed genes |
| SNP | Single nucleotide polymorphism |
| MF | Molecular function |
| CC | Cellular component |
| BP | Biological process |
| CC-5013 | Lenalidomide S1093 was a specific inhibitor in TNF-signaling pathway |
| MTT assay | The method used in this experiment to detect cell viability |
| CCL5 | CC-chemokine 5, a member of the chemokine family |
| CCL20 | CC-chemokine 20, a member of the chemokine family |
| SELE | E-selectin |
| TNFAIP3 | Tumor necrosis factorα inducer protein 3 |